Patents
Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
05/2007
05/23/2007EP1786785A2 Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
05/23/2007EP1786784A2 Catalysis of diketopiperazine synthesis
05/23/2007EP1786777A1 Aminoheteroaryl compounds as protein tyrosine kinase inhibitors
05/23/2007EP1786768A1 Arylsulphonylstilbene derivatives for treatment of insomnia and related conditions
05/23/2007EP1786427A2 Aliphatic amide & ester pyrazinoylguanidine sodium channel blockers
05/23/2007EP1786426A1 Soluble amide & ester pyrazinoylguanidine sodium channel blockers
05/23/2007EP1254895B1 Nitrogenous cyclic compounds and pharmaceutical compositions containing the same
05/23/2007CN1968931A Pyridine analogs as C5A antagonists
05/23/2007CN1966500A Quinoxaline derivative, preparation method and uses
05/22/2007US7220880 For therapy of diabetes mellitus, cardiovascular disease, obesity, Syndrome X and gastrointestinal disease, such as, inflammatory bowel disease
05/22/2007US7220865 For therapy of neurodegenerative and/or neurological disorders, e.g., Alzheimer's disease, in a mammal
05/22/2007US7220781 Meta-benzamidine derivatives as serine protease inhibitors
05/22/2007US7220749 Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
05/22/2007CA2368347C Glucokinase activators
05/22/2007CA2266050C Piperazine derivatives
05/18/2007WO2007029036A3 Amino acid derivatives as histone deacetylase (hdac) inhibitors
05/18/2007WO2007027719A3 Lisofylline analogues and their pharmeacuetical uses
05/18/2007WO2006127458A3 Novel chemical compounds
05/17/2007US20070112194 Process for preparing nitrooxyalkyl substituted esters of carboxylic acids, intermediates useful in said process and preparation thereof
05/17/2007US20070112013 Method of modulating ion channel functional activity
05/17/2007US20070112002 1-[2-(4,4-dimethylcyclohexyl)-5-methoxyphenyl]-4-pentylpiperazine; excellent cell adhesion inhibitory action or cell infiltration inhibitory action; inflammatory diseases and autoimmune diseases such as ulcerative colitis, Crohn's disease, irritable bowel syndrome, rheumatoid arthritis, psoriasis, asthma
05/17/2007US20070108062 Acidic bath for electrolytically depositing a copper deposit containing halogenated or pseudohalogenated monomeric phenazinium compounds
05/16/2007EP1784401A1 Urea derivatives as calcium channel blockers
05/16/2007EP1784394A1 Novel piperidine derivatives as histamine h3 receptor ligands for treatment of depression
05/16/2007CN1964946A 2-propylene-1-ones as hsp70 inducer
05/16/2007CN1962647A Preparation process of intermediate 2-cyanpyrazine of pyrazinamide drug
05/16/2007CN1962646A Synthesis method of key intermediate 2-cyanpyrazine of tuberculosis drug pyrazinamide
05/16/2007CN1962645A N-p-Fluorobenzyl-N-phenoxylacetylpiperazidine derivative preparation method
05/16/2007CN1315806C Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors
05/15/2007US7217740 Diarylsulfones as 5-HT2A antagonists
05/15/2007US7217737 Method and compositions for inhibiting cell proliferative disorders
05/15/2007US7217728 For therapy of reperfusion injury
05/15/2007US7217707 Amide of R-2-(aminoaryl)-propionic acid for use in the prevention of leucocyte activation
05/10/2007WO2007051847A1 Tricyclo substituted amides as glucokinase modulators
05/10/2007WO2006131835A3 Heterocyclic triazines as hypoxic selective protein kinase inhibitors
05/10/2007WO2006120573A3 Heterocyclic n-oxides as hypoxic selective protein kinase inhibitors
05/10/2007WO2006050265A3 Ceramides and apoptosis-signaling ligand
05/10/2007US20070105870 Piperazine derivatives which exhibit activity as serotonin and noradrenaline re-uptake inhibitors
05/10/2007CA2626504A1 Tricyclo substituted amides as glucokinase modulators
05/09/2007EP1783115A1 Arylamine ketones, their preparation methods, the pharmaceutical compositions containing them and their use
05/09/2007EP1781625A1 Substituted amide beta secretase inhibitors
05/09/2007CN1960980A Heterocyclic phenylaminopropanol derivatives as modulators of the monoamine reuptake for the treatment of vasomotor symptoms (VMS)
05/09/2007CN1960978A Amine compound and organic electroluminescent element employing the same
05/09/2007CN1960973A 1-(1h-indol-1-yl)-3-(4-methylpiperazin-1-yl)-1-phenyl propan-2-ol derivatives and related compounds as modulators of the norepinephrine(NE) and the serotonine(5-HT) activity and the monoamine reuptake
05/09/2007CN1958585A Rutheniumú¿IIú®complexes of second generation DNA molecule optical switch, and preparation method
05/09/2007CN1958578A Method for preparing dichloroquinoxaline, and nitro-derivative
05/08/2007US7214715 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques
05/08/2007US7214714 for treatment of renal diseases, cerebrovascular diseases and circulatory diseases
05/08/2007US7214680 2-substituted 1-arylpiperazines as tachykinin antagonists and/or serotonin reuptake inhibitors
05/08/2007US7214677 Benzamide, heteroarylamide and reverse amides
05/08/2007CA2275479C Prevention of loss and restoration of bone mass by certain prostaglandin agonists
05/03/2007WO2007049124A1 Method of making 8-fluoro-naphthalen-1-ylamine and related compounds
05/03/2007WO2007049119A1 A novel compound, useful for pancreatic lipase inhibition and the process for isolation thereof
05/03/2007WO2007048717A1 Preparation of cyclic, ketalized ketones by favorskii rearrangement and the use thereof for the preparation of glucokinase activator 70
05/03/2007WO2007048557A1 Protease inhibitors
05/03/2007WO2006111560A3 2,3 substituted pyrazine sulfonamides as inhibitors of crth2
05/03/2007WO2005094896A3 Targeted serotonin reuptake inhibitors
05/03/2007US20070100144 Method for producing ethyleneamines
05/03/2007US20070099927 Aminoalkyl-pyrazinones and-pyridones as thrombin inhibitors
05/03/2007US20070099921 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
05/03/2007CA2625668A1 Preparation of cyclic, ketalized ketones by favorskii rearrangement and the use thereof for the preparation of glucokinase activator 70
05/03/2007CA2625541A1 Ppar modulating biaromatic compounds
05/02/2007EP1780196A2 Pyridine derivatives for use as vanilloid receptor ligands
05/02/2007EP1778648A2 Compounds useful for inhibiting chk1
05/02/2007EP1575942B1 compounds having selective inhibiting efect at gsk3
05/02/2007EP1482919B1 Pharmaceutical composition that is used to control blood glucose in patients with type 2 diabetes
05/02/2007CN1957001A Alkoxyamines containing a radically polymerizable group
05/02/2007CN1956970A Substituted pyrazinecarboxylic acid anilide derivative or salt thereof, intermediate thereof, agricultural/horticultural agent and use thereof
05/02/2007CN1956969A 2- ( arylalkoxy ) -1- phenylethylamine derivatives as nk1 antagonist and 5-serotonin reuptake inhibitors
05/02/2007CN1956968A Aryl glycinamide derivatives and their use as NK1 antagonists and 5-serotonin reuptake inhibithors
05/02/2007CN1956967A Novel amination process
05/02/2007CN1955164A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
05/02/2007CN1313468C Purification of high-purity triethylenediamine (TEDA) by distillation
05/01/2007US7211670 Method for producing 3-amidinophenylalanine derivatives
04/2007
04/26/2007WO2007045962A2 Novel hdac inhibitors
04/26/2007WO2006099075A3 Certain substituted amides, method of making, and method of use thereof
04/26/2007WO2005105110A3 Doxepin analogs and methods of use thereof
04/26/2007US20070093535 Vinyl phenyl derivatives as GLK activators
04/26/2007US20070093505 2,3-Substituted 5,6-diaryl-pyrazine derivatives as cb1 modulators
04/26/2007US20070093504 Salts of Modulators Of PPAR and Methods of Treating Metabolic Disorders
04/26/2007US20070093491 Novel condensed n-pyrazinyl-sulphonamides and their use in the treament of chemokine mediated diseases
04/26/2007US20070093484 3-Substituted 5,6-diaryl-pyrazine-2-carboxamide and -2-sulfonamide derivatives as cb1 modulators
04/25/2007EP1200824B1 Solid phase synthesis of n,n-disubstituted diazacycloalkylcarboxy derivatives
04/25/2007CN1951923A Sulfur-containing quinoxaline dioxide, method for producing same and their application
04/24/2007US7208600 Inhibitors of serine proteases, particularly HCV NS3-NS4A proteases
04/24/2007US7208599 Reacting an aqueous metal substituted 2-hydroxyalkanesulfonate with a nucleophilic compound in the presence of an alkaline catalyst, mole ratio of both are from 80 to 120 percent of the stoichiometric requirement for the reaction.
04/24/2007US7208493 Vasculostatic agents and methods of use thereof
04/24/2007US7208169 Amidobiphenyloxime derivatives, useful as fungicide or bactericide for protection of crops and materials
04/24/2007CA2281545C N-heterocyclic derivatives as nos inhibitors
04/24/2007CA2075173C Compounds and methods for inhibition of hiv and related viruses
04/19/2007WO2007044729A2 N- (3-amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors
04/19/2007WO2007043680A1 Method of synthesizing quinoxaline derivative by microwave irradiation
04/19/2007WO2007042848A2 Process for the preparation of carbidopa
04/19/2007WO2007042788A2 Acenaphthoquinoxaline sulfonamide derivatives, optical crystal film and method of production thereof
04/19/2007WO2007024833B1 Anthranilamides for controlling invertebrate pests
04/19/2007WO2007017758A3 Novel cysteine protease inhibitors and their therapeutic applications
04/19/2007WO2007017758A2 Novel cysteine protease inhibitors and their therapeutic applications
04/19/2007WO2006110638A3 Inhibitors of akt activity
04/19/2007CA2623768A1 N- (3-amino-quinoxalin-2-yl) -sulfonamide derivatives and their use as phosphatidylinositol 3-kinase inhibitors
04/18/2007EP1773763A1 Lysine based compounds
1 ... 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 ... 187